What is the appropriate use of Kenalog (Triamcinolone)/Lidocaine and Toradol (Ketorolac) injection for an adult patient with significant pain and inflammation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kenalog/Lidocaine and Toradol Injection for Pain and Inflammation

Direct Recommendation

For adult patients with significant pain and inflammation, use intramuscular ketorolac (Toradol) 15-30 mg every 6 hours (maximum 5 days) for acute pain management, and reserve Kenalog (triamcinolone)/lidocaine injections for localized inflammatory conditions requiring targeted corticosteroid therapy. 1, 2

Ketorolac (Toradol) Injectable Use

Appropriate Indications and Dosing

  • Ketorolac is FDA-approved exclusively for short-term (≤5 days) management of moderately severe acute pain requiring opioid-level analgesia, typically in postoperative settings 2
  • For adults age 17-64 years: administer 15-30 mg IM/IV every 6 hours, maximum 120 mg/day 1, 3
  • For adults ≥65 years, renally impaired, or weight <50 kg: reduce to 15 mg every 6 hours 1, 3
  • Ketorolac provides analgesia equivalent to morphine or meperidine, with 40-45% reduction in narcotic requirements when combined with opioids 4, 5

Critical Contraindications (Absolute)

Never administer ketorolac in the following situations 1, 6, 2:

  • Active or history of peptic ulcer disease or GI bleeding
  • Age >60 years with significant alcohol use or hepatic dysfunction
  • Advanced renal impairment, compromised fluid status, or dehydration
  • Thrombocytopenia or concurrent anticoagulant/antiplatelet therapy (including aspirin)
  • Aspirin/NSAID-induced asthma
  • Cerebrovascular bleeding or high cardiovascular risk
  • Pregnancy or labor/delivery
  • Coronary artery bypass graft (CABG) surgery setting
  • Concurrent use with other NSAIDs—toxicities are additive without additional analgesic benefit 1

Required Monitoring

Before initiating ketorolac, obtain baseline blood pressure, BUN, creatinine, liver function tests, complete blood count, and fecal occult blood 1, 3

Discontinue immediately if 1, 6:

  • BUN or creatinine doubles
  • Hypertension develops or worsens
  • Liver function tests increase >3× upper limit of normal
  • Any signs of GI bleeding appear

Kenalog (Triamcinolone)/Lidocaine Injection Use

Appropriate Indications

  • Triamcinolone acetonide injections are indicated for localized inflammatory conditions requiring targeted corticosteroid therapy 7
  • Common applications include intra-articular injections for joint inflammation, epidural injections for radicular pain, or soft tissue injections for localized inflammatory conditions 8
  • The combination with lidocaine provides immediate local anesthetic effect while triamcinolone provides sustained anti-inflammatory action over several weeks 7, 9

Dosing and Administration

  • For intra-articular use: typical dose is 40 mg (2 mL) triamcinolone acetonide mixed with 1-2 mL of 1% lidocaine 10
  • For epidural use: 40 mg triamcinolone mixed with 5 mL of 0.5% preservative-free lidocaine has demonstrated efficacy 8
  • Triamcinolone provides extended duration of effect sustained over several weeks, with adrenal suppression occurring within 24-48 hours and gradually returning to normal in 30-40 days 7

Critical Adverse Event: Postinjection Flare

Be aware that severe postinjection flares can occur 2-24 hours after triamcinolone injection, mimicking septic arthritis 10:

  • Symptoms include acute joint swelling, intense pain, and inability to ambulate
  • Synovial fluid may appear "butterscotch"-colored with triamcinolone crystals visible on polarized light microscopy
  • This represents an acute crystal-induced inflammatory response, not infection
  • Always inform patients of this potential complication before injection 10

Clinical Decision Algorithm

For Acute Inflammatory Pain

  1. If pain is associated with inflammation and requires systemic treatment: Use ketorolac 15-30 mg IM every 6 hours for maximum 5 days 11, 1
  2. If pain is localized to a specific joint or soft tissue structure: Consider Kenalog/lidocaine injection for targeted therapy 9, 8
  3. Never combine ketorolac with other NSAIDs or use beyond 5 days 1, 2

For Pain with Inflammatory Component

  • NSAIDs or glucocorticoids are recommended as a trial for pain associated with inflammation 11
  • Standard NSAIDs (ibuprofen 600 mg up to 4 times daily) have better safety profiles for sustained use than ketorolac 1
  • For neuropathic components, add gabapentin (starting 100-300 mg nightly, titrate to 900-3600 mg/day) or pregabalin (starting 50 mg three times daily) 11, 1

Common Pitfalls to Avoid

With Ketorolac

  • Never exceed 5 days total duration—this is an FDA black box warning 2
  • Never combine with other NSAIDs, including ibuprofen—this significantly increases GI bleeding, renal failure, and cardiovascular event risks 1
  • Do not use as prophylactic analgesic before major surgery 2
  • Avoid intrathecal or epidural administration due to alcohol content 2

With Kenalog/Lidocaine

  • Always use preservative-free lidocaine for epidural injections 8
  • Warn patients about potential postinjection flare that can mimic infection 10
  • Consider aspiration and synovial fluid analysis if severe symptoms develop post-injection to rule out septic arthritis 10

Alternative Approaches

When ketorolac is contraindicated or for longer-term management 1:

  • Standard NSAIDs (ibuprofen, naproxen) for mild-moderate pain
  • Acetaminophen up to 4g daily
  • Topical NSAIDs (diclofenac gel) for localized pain
  • Lidocaine patches for neuropathic components
  • Opioids for severe pain when NSAIDs are contraindicated

References

Guideline

Ketorolac for Acute Neck Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Ketorolac Dosage and Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Contraindications and Precautions for Ketorolac Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Extreme Postinjection Flare in Response to Intra-Articular Triamcinolone Acetonide (Kenalog).

American journal of orthopedics (Belle Mead, N.J.), 2016

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.